PT  - JOURNAL ARTICLE
AU  - Nierengarten, Mary Beth
ED  - van der Heijde, Desiree
TI  - FUTURE 1: Secukinumab Inhibits Radiographic Disease Progression in PsA
DP  - 2014  01
TA  - MD Conference Express
PG  - 15--17
VI  - 14
IP  - 51
4099  - http://mdc.sagepub.com/content/14/51/15.short
4100  - http://mdc.sagepub.com/content/14/51/15.full
AB  - This article presents the relevant radiographic data for the Efficacy at 24 Weeks and Long-Term Safety, Tolerability, and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) trial [FUTURE 1; NCT01392326]. Analysis specifically focuses on one of the secondary outcomes of the study, radiographic analysis at week 24 (primary analysis) and radiographic analysis at week 52 (secondary analysis).